Australia has a set of stringent regulatory requirements for medical devices. However, it still needs to improve its Australian regulatory framework. As part of this objective, the Australian Government, with the Therapeutic Goods Administration (TGA), continues to exert efforts to improve health outcomes for patients who need medical devices.
One example is the TGA’s UDI consultation proposals. These consultations are also part of the TGA’s broader stakeholder engagement work.
So, what is usually outlined in a TGA’s consultation proposal for establishing a UDI system in Australia? Who can participate, and what has the TGA done so far?
This blog post will answer these questions. It will look into the intent of the TGA’s consultations for the full implementation of medical devices. It will also discuss who can participate in these consultations and what has been accomplished to date.
Understanding the Implementation of a Unique Device Identification System
In October 2020, the Australian Government announced its plans to strengthen patient safety by establishing an Australian UDI system for medical devices. The proposed UDI framework will cover all essential aspects, including the production of the UDI, the UDI application for the labelling of medical devices, as well as the maintenance of the UDI Database to store the data related to the unique device identifiers. The system will help improve the tracking and tracing of medical devices that have been implanted in patients.
In February 2021, changes were introduced to the Therapeutic Goods Act.
These changes include the following:
- Data collection for the UDI database
- Creation of data collection regulations
- Regulations surrounding device labels
The government also determined that the TGA will establish and maintain the Australian Unique Device Identification Database (AusUDID).
TGA’s UDI Consultations: Approach and Purpose
The TGA continues to seek feedback from stakeholders for implementing a UDI system in Australia. This is part of the effort of the Australian Government to improve the safety, performance, and quality of medical devices distributed in the Australian market. This is where the UDI consultations come into the picture.
TGA UDI consultation papers are published to initiate a public discussion with industry representatives and other parties involved in operations with medical devices. Another purpose of the UDI consultations is to understand the medical device problems they are trying to solve and respond to the community’s needs.
The TGA, through these consultations, will inform the planning and design of theAustralian UDI implementation. Furthermore, each proposal contains key topic areas that should be considered as they progress with the process (read more below).
The consultations may include papers, stakeholder workshops, discussions and working groups. To know more about the open TGA consultations you can participate in, go to https://consultations.tga.gov.au/.
Who Can Participate in the UDI Consultations?
As outlined, with the UDI consultations, the TGA will engage with the industry to obtain all perspectives for developing and implementing the UDI system. Specifically, the TGA will consider the feedback of consumers of medical devices.
Among the list of stakeholders that can review the proposed regulatory changes critical to the development and implementation of the UDI system include:
- Patient
- Manufacturer
- Healthcare organisation
- Healthcare provider
- Healthcare professional
- Industry representative body
- Consumer advocacy group
- Researcher
- Other interested parties
With the interested parties’ input, the TGA will address unintended consequences and better inform the proposals. TGA will review all submissions and publish feedback through its website.
The UDI Consultations through the Years
Feedback to inform the planning and design of an Australian UDI system has been sought through the following proposals:
Consultation Paper 1: Proposal to introduce a Unique Device Identification (UDI) system for medical devices in Australia
The TGA UDI consultation in January 2019 proposed implementing changes to how the TGA regulates medicines, medical devices, and biologicals. The consultation paper was also issued as part of the Australian Government’s reform program regulating therapeutic goods in Australia. The consultation aimed to explore the likelihood of implementing a UDI system in Australia and options for developing the UDI database (AusUDID).
Consultation Paper 2: Exploring options for the introduction of an Australian Unique Device Identification (UDI) system
In September 2020, the TGA published a consultation on UDI’s potential applications in the broader healthcare system. This consultation paper was built on the previous consultation paper, the proposed introduction of a UDI system for medical devices in Australia.
Consultation Paper 3: Detailed considerations for implementing the proposed Australian medical device UDI regulatory framework
The third consultation was published in August 2022 and relates to the Australian implementation of a Unique Device Identification (UDI) System for medical devices. This proposal was built on the first 2 consultation proposals and sought feedback on considerations, including the impact of accepting both European and USA-compliant labels, UDI labelling and supporting documentation, scope and exemptions in UDI application, and adoption of UDI and its use in the broader healthcare setting, among others.
What Are the Benefits of an Australian UDI System?
A fully implemented UDI system in Australia will improve the transparency and traceability of medical devices distributed across the market. The elements will also be used for both pre-market and post-market stages.
An Australian UDI system will not only improve medical device identification and strengthen patient safety.
It will offer benefits to healthcare providers, consumers, hospitals, regulators, and the industry by enabling the following:
- Actions associated with medical device recalls and their effectiveness
- Faster discovery of faulty medical devices
- Reduction in medical and surgical procedural errors
- More time spent with patients
- Adoption of a global medical device identification system
- Improved assessment of a device’s performance
- More informed patient treatment
- Seamless access to information related to medical devices marketed in Australia for individual customers
- Mitigate risks with a short supply of medical devices
Talk to Vicki Partridge
Vicki Partridge is a reputable medical device regulatory affairs consultant with 15 years of experience working with the TGA. Talk to Vicki Partridge for more information about the TGA’s UDI consultation benefits to implementing the UDI system in Australia.
Vicki can handle all your medical device consulting services requirements, from compliance consultations to training workshops. Call +61 7 55295508 now.